Michael Schamroth

Michael Schamroth appears in our data through filings on Biospecifics Technologies Corp shares, published by SEC (Form 4). Between 27 January 2016 and 2 December 2020, the trades on record add up to 8 filings.

Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The latest filing, published on 2 December 2020, reports a transaction in Biospecifics Technologies Corp. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.